89bio Inc. (ETNB)

Name: 89bio Inc. (ETNB) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: 89bio Inc. (ETNB)

Stock Card

$14.84

$0.00 (0.00%)

As on 30-Oct-2025 09:30EDT

Market cap

$2,204 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

4.2

Div. Yield

0 %

89bio (ETNB) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 14.84 High: 14.84

52 Week Range

Low: 4.16 High: 15.06

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.9 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-2.7
Debt to Equity

0.1
Book Value

$--
EPS

$-3.7
Face value

--
Shares outstanding

148,492,428

6 Years Aggregate

CFO

$-371.23 Mln

EBITDA

$-433.92 Mln

Net Profit

$-457.43 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
89bio (ETNB)	89.8	1.0	61.0	81.4	16.9	-9.3	--
BSE Sensex^*	-8.8	0.6	1.8	-4.4	6.0	6.6	10.8
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 30-Oct-2025 | *As on 28-Aug-2026 | #As on 26-Oct-2023

Company	2024	2023	2022	2021	2020
89bio (ETNB)	-29.8	-12.3	-2.6	-46.4	-7.3
S&P Small-Cap 600	7.0	13.9	-17.4	25.3	9.6
BSE Sensex	8.1	18.7	4.4	22.0	15.8

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Shareholding Pattern

View Details

About 89bio (ETNB)

89bio, Inc., a clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of... fibroblast growth factor 21 for the treatment of metabolic dysfunction-associated steatohepatitis and hypertriglyceridemia. 89bio, Inc. was formerly known as The company was founded in 2018 and is based in San Francisco, California. As of October 29, 2025, 89bio, Inc. operates as a subsidiary of Roche Holding AG. Read more

CEO & Director

Mr. Rohan Palekar
CEO & Director

Mr. Rohan Palekar
Headquarters

San Francisco, CA
Website

https://www.89bio.com

FAQs for 89bio (ETNB)

What is the current share price of 89bio Inc (ETNB) Today?

The share price of 89bio Inc (ETNB) is $14.84 (NASDAQ) as of 30-Oct-2025 09:30 EDT. 89bio Inc (ETNB) has given a return of 16.9% in the last 3 years.

What is the current PB & PE ratio of 89bio Inc (ETNB)?

Since, TTM earnings of 89bio Inc (ETNB) is negative, P/E ratio is not available.
The P/B ratio of 89bio Inc (ETNB) is 4.22 times as on 30-Oct-2025, a 21 discount to its peers’ median range of 5.35 times.

PE & PB ratio at the end of financial year.